Perceptive Advisors
Perceptive Advisors, founded in 1999, is a venture capital firm focused on supporting progress in the life sciences industry. The firm manages approximately $8 billion across various strategies, investing in transformative technologies within healthcare. Perceptive Advisors is dedicated to identifying opportunities and directing financial resources toward the most promising innovations in modern healthcare, with a strong emphasis on scientific, technical, and investment expertise.
Perceptive Advisors
51 Astor Place, 10th floor, New York, NY 10003
What We Do
Perceptive Advisors provides venture capital through the Perceptive Xontogeny Venture Fund, focusing on early-stage life sciences companies, primarily seed and Series A investments. The firm partners with founders and entrepreneurs, offering operational and strategic support as Board members to drive successful outcomes.
The firm offers customized debt financing solutions to innovative healthcare companies, providing minimally-dilutive capital across all stages and subsectors. This includes funding for R&D, acquisitions, and commercial scale-up.
Perceptive Discovery Fund provides capital solutions to high conviction private and public life sciences company opportunities, focusing on later-stage development and commercial-stage companies. The fund offers structured solutions in the form of preferred equity and/or convertible debt.
Industry Focus
Show LessInvestment Range
Portfolio
Developing novel cancer immunotherapies targeting clonal neoantigens.
#Biopharmaceuticals
Key People
Chief Executive Officer & Portfolio Manager
Chief Investment Officer
Managing Director